Related Experiment Video

Updated: Aug 8, 2026

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae
10:45

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae

Published on: July 30, 2012

Invasive fungal infection occurring in low birthweight infants

Kathryn Godfrey

    Nursing Times
    |January 7, 2004
    PubMed

    Insights

    A national study is tracking invasive fungal infections in low birthweight infants. Rising cases in premature babies are linked to increased survival rates and intensive care needs.

    Area of Science:

    • Neonatalogy
    • Infectious Diseases
    • Public Health Surveillance

    Background:

    • Invasive fungal infections (IFIs) pose a significant threat to low birthweight infants.
    • Candida species are a leading cause of morbidity and mortality in premature neonates.
    • Improved survival rates in extremely premature infants contribute to increased IFI incidence.

    Purpose of the Study:

    • To conduct a national surveillance study on the incidence of invasive fungal infections in low birthweight infants.
    • To investigate the rising trend of IFIs in this vulnerable population.
    • To inform strategies for prevention and management of IFIs in neonates.

    Main Methods:

    • A national surveillance study design was implemented.
    • Data collection focused on low birthweight infants, specifically those weighing under 1,500 grams.
    • Epidemiological data on IFI rates were analyzed.

    Main Results:

    • The estimated rate of fungal infection is approximately 2 in 100 babies born weighing less than 1,500 g.
    • The increasing incidence of IFIs is associated with improved survival of extremely premature infants (25-26 weeks' gestation).
    • These infants require more intensive and invasive care, increasing their susceptibility.

    Conclusions:

    • There is a notable rate of invasive fungal infection in low birthweight infants.
    • Advances in neonatal care, while improving survival, have inadvertently increased the risk of IFIs.
    • Continued surveillance and targeted interventions are crucial for managing IFIs in this population.

    More Related Videos

    An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

    An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

    Published on: July 1, 2020

    Use of In Vivo Imaging to Screen for Morphogenesis Phenotypes in Candida albicans Mutant Strains During Active Infection in a Mammalian Host09:24

    Use of In Vivo Imaging to Screen for Morphogenesis Phenotypes in Candida albicans Mutant Strains During Active Infection in a Mammalian Host

    Published on: October 12, 2022

    Related Concept Videos

    Factors Affecting the Risk of Infection01:26

    Factors Affecting the Risk of Infection

    The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
    The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
    Fungal Phylum Microsporidia01:28

    Fungal Phylum Microsporidia

    Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
    Development of the Oral Microbiota01:28

    Development of the Oral Microbiota

    The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Candidiasis01:20

    Candidiasis

    Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
    Antifungal Agents01:15

    Antifungal Agents

    Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...